Sema4’s Acquisition of GeneDx

Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here